All rights reserved.

The University of Michigan Scleroderma Program was organized in 2004 concomitant with the arrival of its director, James R. Seibold,
M.D., Marvin & Betty Danto Research Professor and Professor of Internal Medicine at the University of Michigan Medical School.  

Scleroderma is an inherently complex disease which is best addressed by a multidisciplinary team approach to treatment and
research.  The University of Michigan Medical School is one of the leading research institutions in the world.  Its clinical and scientific
assets are extensive, cutting edge and uniquely suited to the needs of the scleroderma community.

The goals of the Scleroderma Program are to develop effective therapies for scleroderma and its complications and to research the
causes and mechanisms of disease.  It is only through enhanced understanding of disease process that cure will be possible.

Based in the Division of Rheumatology, faculty from many disciplines, including Pulmonary Medicine, the Pulmonary Hypertension
Program of the Division of Cardiology, Pediatric Rheumatology, the Department of Dermatology, the Division of Hand Surgery, the
Department of Occupational Therapy; and the University of Michigan Cancer Center, currently participate in Program activities.

The Scleroderma Program provides clinical care, primarily on a consultative basis to patients from Michigan and the Midwest, but
also serves as an international referral center.

Program activities include development and performance of complex trials designed to improve the quality of life and extend survival.  
Crucial to this enterprise is refined investigation of the science of outcome measures, which in turn, leads to more robustly designed
clinical trials for the future.  An effective and talented team has been assembled and a broad portfolio of research is in progress.

Increasing focus is on initiatives in research into the cause and pathobiology of scleroderma.  Basic scientists are active at the
University of Michigan in areas of direct relevance to scleroderma including the biology of fibrosis, vascular biology, and basic cellular
immunology.  

The Scleroderma Program at the University of Michigan is dedicated to advancing research and improving care for patients with
scleroderma and related diseases.  

For more information, or to make a donation, please call 734-763-3110 or visit our website:
The beneficiary of this year's Greatest 5K Ever is the
University of Michigan Scleroderma Program
Domino's Farms
24 Frank Lloyd Wright Drive
P.O. Box 481, Lobby M, Suite 2500
Ann Arbor, MI 48106